Mefenorex: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Mefenorex.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Mefenorex.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview=='''Mefenorex''' ('''Rondimen''', '''Pondinil''', '''Anexate''') is a [[stimulant]] drug which was used as an [[appetite suppressant]]. It is an [[amphetamine]] derivative which was developed in the 1970s and used for the treatment of [[obesity]].<ref>Vincendeau MJ. A new regulator of appetite: mefenorex. (French). ''Bordeaux Medical''. 1970 Jul-Aug;3(7):1951-3.</ref><ref>Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). ''Die Medizinische Welt''. 1980 Feb;31(8):306-9.</ref> Mefenorex produces [[amphetamine]] as a [[metabolite]],<ref>Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. ''European Journal of Drug Metabolism and Pharmacokinetics''. 1994 Apr-Jun;19(2):107-17. </ref> and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.<ref>Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). ''Drug and Alcohol Dependence''. 1986 Jun;17(2-3):229-34.</ref> | ==Overview== | ||
'''Mefenorex''' ('''Rondimen''', '''Pondinil''', '''Anexate''') is a [[stimulant]] drug which was used as an [[appetite suppressant]]. It is an [[amphetamine]] derivative which was developed in the 1970s and used for the treatment of [[obesity]].<ref>Vincendeau MJ. A new regulator of appetite: mefenorex. (French). ''Bordeaux Medical''. 1970 Jul-Aug;3(7):1951-3.</ref><ref>Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). ''Die Medizinische Welt''. 1980 Feb;31(8):306-9.</ref> Mefenorex produces [[amphetamine]] as a [[metabolite]],<ref>Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. ''European Journal of Drug Metabolism and Pharmacokinetics''. 1994 Apr-Jun;19(2):107-17. </ref> and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.<ref>Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). ''Drug and Alcohol Dependence''. 1986 Jun;17(2-3):229-34.</ref> | |||
== References == | == References == | ||
Line 14: | Line 11: | ||
{{Stimulants}} | {{Stimulants}} | ||
{{Phenethylamines}} | {{Phenethylamines}} | ||
[[Category:Organochlorides]] | [[Category:Organochlorides]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Revision as of 13:30, 8 April 2015
WikiDoc Resources for Mefenorex |
Articles |
---|
Most recent articles on Mefenorex |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Mefenorex at Clinical Trials.gov Clinical Trials on Mefenorex at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Mefenorex
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Mefenorex Discussion groups on Mefenorex Directions to Hospitals Treating Mefenorex Risk calculators and risk factors for Mefenorex
|
Healthcare Provider Resources |
Causes & Risk Factors for Mefenorex |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]
References
- ↑ Vincendeau MJ. A new regulator of appetite: mefenorex. (French). Bordeaux Medical. 1970 Jul-Aug;3(7):1951-3.
- ↑ Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). Die Medizinische Welt. 1980 Feb;31(8):306-9.
- ↑ Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 1994 Apr-Jun;19(2):107-17.
- ↑ Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). Drug and Alcohol Dependence. 1986 Jun;17(2-3):229-34.